This article is freely available to all

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Quetiapine, a dibenzothiazepine derivative producedby altering the structure of the clozapine molecule, has beenshown to have low to moderate affinity for the D1, D2, 5-HT1A,and 5-HT2A receptors and moderate to high affinity for the a1-and a2-adrenergic receptors. Due to this receptor profile, quetiapinehas been claimed to have a low incidence of extrapyramidalside effects. Large controlled trials have also shown thatquetiapine is associated with placebo-level extrapyramidal sideeffects and akathisia in schizophrenia and bipolar disorder.’ ‹’ ‹